Benitec Biopharma Inc. (BNTC)

Benitec Biopharma Ratios and Metrics

Market cap in millions USD. Fiscal year is July - June.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jan 9, 2026	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
Market Capitalization	406	307	65	7	9	33
Market Cap Growth	53.14%	369.05%	881.17%	-29.60%	-71.60%	294.06%
Enterprise Value	320	205	52	1	2	22
Last Close Price	12.18	11.70	6.99	4.05	19.72	72.25
PS Ratio	-	-	-	88.98	129.85	565.78
PB Ratio	3.42	3.16	1.39	33.04	3.29	1.67
P/TBV Ratio	4.42	3.16	1.39	33.04	3.29	1.67
EV/Sales Ratio	-	-	-	9.94	23.51	367.04
Debt / Equity Ratio	0.01	0.01	0.01	2.77	0.28	0.01
Asset Turnover	-	-	-	0.01	0.01	0.00
Quick Ratio	46.66	54.26	10.38	0.64	1.61	14.46
Current Ratio	46.95	54.67	10.49	0.94	1.90	15.05
Return on Equity (ROE)	-53.02%	-52.46%	-91.68%	-1268.61%	-159.08%	-91.79%
Return on Assets (ROA)	-34.72%	-34.39%	-49.60%	-228.53%	-81.59%	-51.55%
Return on Capital (ROIC)	-36.03%	-35.84%	-58.21%	-535.50%	-93.32%	-55.06%
Return on Capital Employed (ROCE)	-48.70%	-42.70%	-47.60%	-3926.10%	-518.90%	-67.90%
Earnings Yield	-10.11%	-12.35%	-33.22%	-293.13%	-192.09%	-41.59%
FCF Yield	-5.41%	-7.69%	-29.91%	-269.92%	-167.86%	-39.10%
Buyback Yield / Dilution	-59.78%	-97.17%	-1225.17%	-188.30%	-90.24%	-320.63%

Updated Nov 14, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q